OCA-GA Sponsor and Present

(with partial funding from NAAAP/CFC grant)

Speaker :  Dr. Jung-Chung Lin (林榮寵)

Professor Emeritus

American Association for Cancer Research

Pre-lecture bi-lingual slides and Hepatitis B Awareness flyer

distributed/presented by

         Emory University Asian Pacific American

         Medical Student Association

   Time:       Noon, Wednesday, August 12, Monthly Luncheon

                   Asian American Senior Citizen Association 

(AASCA)

   Place:      Chinese  Community Center (tel) 770/451-4456

                       5377 New Peachtree Rd., Atlanta, GA 30341

RSVP by August 8th, 2015 - joan.goh@oca-georgia.org

$5.00/box lunch pay at the registration desk

    Dr. Jung-Chung Lin has held faculty positions at University of North Carolina at Chapel  Hill. He also served as section chief of tumor virology at the Centers for Disease Control, Atlanta, Georgia and was director of the Institute of Molecular  Medicine at Tzu Chi   University, Taiwan. Currently he is a Professor Emeritus at the American Association for Cancer Research.  

     According to Dr. Howard K. Koh, MD, MPH, Assistant Secretary for Health, U.S. Department of Health and Human Services, Asian and Pacific Islanders are at higher risk for Hepatitis B, which can lead to liver cancer.  Early diagnosis of Hepatitis B and access to lifesaving medical care can help reduce these inequalities.

Asian and Pacific Islanders (APIs) make up less than 5% of the total United   States population but account for more that 50% of Americans living with chronic Hepatitis B. Despite these high rates, many APIs are not tested for Hepatitis B. They are unaware of their infection and many recent immigrants do not have access to necessary medical services that can help save lives.  As a result, chronic Hepatitis B and associated liver cancer in APIs is one of the most serious health disparities in the United States.

Knowledge of Hepatitis B varies greatly in the API community and there are many misperceptions about the disease.  Lack of knowledge and awareness contributes to the low testing rates in the API population. Awareness, education and action are key for APIs community to effectively address its ties to hepatitis B (HB).